TSP903-CMap - carcinogenome project: Toxicogenomic signatures after exposure to n-nitrosopiperidine


TSA9577-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine


TSA8685-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine


TSA9686-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine


TSF12764-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 100.46 µM


1 subfactor(s)
TSF12765-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 33.49 µM


1 subfactor(s)
TSF12766-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 11.16 µM


1 subfactor(s)
TSF9304-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 4.98 µM


1 subfactor(s)
TSF9301-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 39.8 µM


1 subfactor(s)
TSF9305-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 2.49 µM


1 subfactor(s)
TSF9302-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 19.9 µM


1 subfactor(s)
TSF9303-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 9.95 µM


1 subfactor(s)
TSF9306-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 1.24 µM


1 subfactor(s)
TSF13097-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 100.46 µM


1 subfactor(s)
TSF13098-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 33.49 µM


1 subfactor(s)
TSF13099-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 11.16 µM


1 subfactor(s)
TSS12765-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 100.46 µM


TSS12766-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 33.49 µM


TSS12767-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.TP53.M after exposure to n-nitrosopiperidine 11.16 µM


TSS9304-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 4.98 µM


TSS9301-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 39.8 µM


TSS9305-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 2.49 µM


TSS9302-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 19.9 µM


TSS9303-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 9.95 µM


TSS9306-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line HEPG2 after exposure to n-nitrosopiperidine 1.24 µM


TSS13098-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 100.46 µM


TSS13099-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 33.49 µM


TSS13100-CMap - carcinogenome project: Toxicogenomic signatures in the human cell line MCF10A.WT.HP after exposure to n-nitrosopiperidine 11.16 µM



TSP903 - CMap - carcinogenome project: Toxicogenomic signatures after exposure to n-nitrosopiperidine Public


In the chemical selection process, we prioritized chemicals with long-term rodent liver carcinogenicity annotation for inclusion in this experiment. Long-term carcinogenicity annotations were derived from the Carcinogenic Potency Database (CPDB) (Fitzpatrick 2008). Additional chemicals without carcinogenicity annotation were included on the basis of interest to the Superfund Research Program (environmental toxicants), presence in controversial commercial products (included for predictive purposes), and evidence of binding to the aryl hydrocarbon receptor (AhR), as the AhR is an important mediator of xenobiotics, including carcinogens. In total, 330 unique chemicals were used in the analysis, including 128 carcinogens, 168 noncarcinogens, 100 genotoxicants, and 161 nongenotoxicants. (Li et al., 2019) Liver Carcinogenicitycarcinogen Liver Genotoxicitygenotoxic

Experimental design


No experimental design provided

Results


No results provided